![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No Clinically Meaningful Effect of Single- and Multiple-Dose Administration of Peginterferon Lambda-1a on the QTc Interval
|
|
|
Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy. Washington DC, May 19-21, 2014.
Hruska M,1 Xu D,2 Jurkowski C,1 Bounous D,3 Cooney E,2 Srinivasan S,2 Bertz R1
1Bristol-Myers Squibb Research and Development, Hopewell, NJ; 2Bristol-Myers Squibb Research and Development, Wallingford, CT; 3Bristol-Myers Squibb Research and Development, Princeton, NJ
![Pharm1.gif](../images/052314/052314-6/Pharm1.gif)
![Pharm2.gif](../images/052314/052314-6/Pharm2.gif)
![Pharm3.gif](../images/052314/052314-6/Pharm3.gif)
![Pharm4.gif](../images/052314/052314-6/Pharm4.gif)
![Pharm5.gif](../images/052314/052314-6/Pharm5.gif)
![Pharm6.gif](../images/052314/052314-6/Pharm6.gif)
![Pharm7.gif](../images/052314/052314-6/Pharm7.gif)
![Pharm8.gif](../images/052314/052314-6/Pharm8.gif)
![Pharm9.gif](../images/052314/052314-6/Pharm9.gif)
![Pharm10.gif](../images/052314/052314-6/Pharm10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|